科研成果

人才招聘 下载中心

2024年10月,戴克胜课题组在Int J Mol Sci杂志上发表论文

发布日期:2024-12-31

Int J Mol Sci. 2024 Oct 27;25(21):11548. doi: 10.3390/ijms252111548.

 

题目:

Platelet Glycoprotein Ibα Cytoplasmic Tail Exacerbates Thrombosis During Bacterial Sepsis

 

作者:

Yue Xia#, Chenglin Sun#, Kangxi Zhou, Jie Shen, Jiaojiao Li, Qiuxia Huang, Jiahao Du, Sai Zhang, Kang Sun, Renping Hu, Rong Yan*, Kesheng Dai*

#These authors contributed equally

*Corresponding author

 

摘要:

Septic patients, coupling severe disseminated intravascular coagulation (DIC) and thrombocytopenia, have poor prognoses and higher mortality. The platelet glycoprotein Ibα (GPIbα) is involved in thrombosis, hemostasis, and inflammation response. However, it remains unclear whether the GPIbα cytoplasmic tail regulates sepsis-mediated platelet activation and inflammation, especially in Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) infections. Using a mouse model of S. aureus-induced bacteremia, we found that both 10 amino acids of GPIbα C-terminal sequence deficiency and pharmacologic inhibition of protein kinase C (PKC) alleviated pathogenesis by diminishing platelet activation and aggregate formation. Furthermore, the GPIbα cytoplasmic tail promoted the phagocytosis of platelets by Kupffer cells in vivo. The genetically deficient GPIbα cytoplasmic tail also downregulated inflammatory cytokines and reduced liver damage, ultimately improving the survival rate of the septic mice. Our results illustrate that the platelet GPIbα cytoplasmic domain exacerbates excessive platelet activation and inflammation associated with sepsis through a PKC-dependent pathway. Thus, our findings provide insights for the development of effective therapeutic strategies using PKC inhibitor treatment against bacterial infection.